Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Stocks Close Higher After Positive Retail Data
Veronica Willis, investment strategy analyst with Wells Fargo Investment Institute, joined Cheddar News to discuss Wednesday's trading session following better-than-expected retail sales and what's on tap for the markets this year.
Load More